The ARQL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARQL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ARQL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ARQL Detailed Price Forecast - CNN Money||View ARQL Detailed Summary - Google Finance|
|View ARQL Detailed Summary - Yahoo! Finance||View ARQL Stock Research & Analysis - Zacks.com|
|View ARQL Trends & Analysis - Trade-Ideas||View ARQL Major Holders - Barrons|
|View ARQL Call Transcripts - NASDAQ||View ARQL Breaking News & Analysis - Seeking Alpha|
|View ARQL Annual Report - CompanySpotlight.com||View ARQL OTC Short Report - OTCShortReport.com|
|View ARQL Fundamentals - TradeKing||View ARQL SEC Filings - Bar Chart|
|View Historical Prices for ARQL - The WSJ||View Performance/Total Return for ARQL - Morningstar|
|View the Analyst Estimates for ARQL - MarketWatch||View the Earnings History for ARQL - CNBC|
|View the ARQL Earnings - StockMarketWatch||View ARQL Buy or Sell Recommendations - MacroAxis|
|View the ARQL Bullish Patterns - American Bulls||View ARQL Short Pain Metrics - ShortPainBot.com|
|View ARQL Stock Mentions - StockTwits||View ARQL Stock Mentions - PennyStockTweets|
|View ARQL Stock Mentions - Twitter||View ARQL Investment Forum News - Investor Hub|
|View ARQL Stock Mentions - Yahoo! Message Board||View ARQL Stock Mentions - Seeking Alpha|
|View Insider Transactions for ARQL - SECform4.com||View Insider Transactions for ARQL - Insider Cow|
|View ARQL Major Holdings Summary - CNBC||View Insider Disclosure for ARQL - OTC Markets|
|View Insider Transactions for ARQL - Yahoo! Finance||View Institutional Holdings for ARQL - NASDAQ|
|View ARQL Stock Insight & Charts - FinViz.com||View ARQL Investment Charts - StockCharts.com|
|View ARQL Stock Overview & Charts - BarChart||View ARQL User Generated Charts - Trading View|
ArQule to Report Second Quarter 2018 Financial Results on August 1, 2018
Posted on Wednesday July 18, 2018
ArQule, Inc. (ARQL) today announced it will report financial results for the second quarter of 2018 before the market opens on Wednesday, August 1, 2018. The Company will hold a conference call and webcast on the same day at 9:00 a.m. ET to discuss these results and provide a general business update. ArQule is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases.
The 4 Best Biotech Stocks of 2018 (So Far)
Posted on Saturday July 14, 2018
Find out what's pushing shares of these biotechs through the roof.
ArQule Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
Posted on Friday July 13, 2018
ArQule, Inc. (ARQL) today announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,650,000 shares at the public offering price of $5.50 per share. The exercise of the option to purchase additional shares brought the total number of shares of common stock sold by ArQule to 12,650,000 shares and increased the gross proceeds raised in the offering, before deducting underwriting discounts and commissions and estimated expenses of the offering payable by ArQule, to approximately $70 million. Needham & Company, LLC acted as lead co-manager, and Roth Capital Partners, B. Riley FBR and JonesTrading Institutional Services LLC acted as co-managers for the offering.
Free Pre-Market Technical Recap on ArQule and Three Additional Biotech
Posted on Thursday July 12, 2018
On Wednesday, July 11, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Eight out of nine sectors ended Wednesday's trading session in bearish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Biotechnology equities this morning: Arena Pharmaceuticals Inc. (NASDAQ: ARNA), ArQule Inc. (NASDAQ: ARQL), Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR), and Atara Biotherapeutics Inc. (NASDAQ: ATRA).